Search
for
Sort by
Research 391–420 of 1000+
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Treatments for alopecia areata: a network meta-analysis
- Successful treatment of alopecia universalis with abrocitinib: a case report
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Baricitinib-loaded separable microneedle array patch (S-MAP) based on hyaluronic acid for alopecia areata therapy
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Microneedles: Selected Applications for Pediatrics
- Could baricitinib treat frontal fibrosing alopecia and facial papules?
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Baricitinib: A Review in Severe Alopecia Areata
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Current Treatments for Alopecia Areata
- Vitiligo—Current Treatment Options and Future Perspectives
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Frontal Fibrosing Alopecia: A Comprehensive Review with Recent Updates
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Biologics in the management of childhood atopic dermatitis
- Novel potential therapeutic targets of alopecia areata
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- The Skin Microenvironment: A Dynamic Regulator of Hair Follicle Development, Cycling and Disease
- Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Establishment of an in vitro organoid model of dermal papilla of human hair follicle
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Baricitinib in the Treatment of Frontal Fibrosing Alopecia: Mid Trial Update